Top Stories: California sues drug makers; GH Healthcare acquires IMPACTIS

Photo: Pichsakul Promrungsee EyeEm/Getty Images

The state of California is suing pharmaceutical manufacturers. Why do they do it? We’ll cover the answers to this and other questions in this week’s Breaking News, including GE Healthcare’s deal with France’s IMPACTIS, and the recent SickKids ransomware threat.

For more news and articles from Jeff Lagasse, visit Healthcare Finance News.

In this episode:

Topics for conversation:

• The lawsuit alleges that manufacturers Eli Lilly, Novo Nordisk and Sanofi, as well as pharmacy benefits managers CVS Caremark, Express Scripts and OptumRx used their bargaining power to inflate prices for patients.
• The three manufacturers named in the lawsuit produce more than 90% of the world’s insulin supply, and the three PBMs manage pharmacy benefits for about 80% of processed prescription claims.
• Financial details of the deal were not disclosed, but GE HealthCare said it plans to fund the acquisition with cash.
• UHN announced that there was no patient data breach and indicated that the failure was due to problems with its network.

Twitter: @JELagasse
Write to the writer: [email protected]